Journal article
The role of immune correlates of protection on the pathway to licensure, policy decision and use of group B Streptococcus vaccines for maternal immunization: considerations from World Health Organization consultations
- Abstract:
-
The development of a group B Streptococcus (GBS) vaccine for maternal immunization constitutes a global public health priority, to prevent GBS-associated early life invasive disease, stillbirth, premature birth, maternal sepsis, adverse neurodevelopmental consequences, and to reduce perinatal antibiotic use. Sample size requirements for the conduct of a randomized placebo-controlled trial to assess vaccine efficacy against the most relevant clinical endpoints, under conditions of appropriate ...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Version of record, pdf, 339.5KB)
-
- Publisher copy:
- 10.1016/j.vaccine.2019.04.039
Authors
Bibliographic Details
- Publisher:
- Elsevier Publisher's website
- Journal:
- Vaccine Journal website
- Volume:
- 37
- Issue:
- 24
- Pages:
- 3190-3198
- Publication date:
- 2019-04-25
- Acceptance date:
- 2019-04-11
- DOI:
- EISSN:
-
1873-2518
- ISSN:
-
0264-410X
Item Description
- Keywords:
- Pubs id:
-
pubs:995523
- UUID:
-
uuid:1d92ec32-02fc-4223-9d1d-f9541521ae72
- Local pid:
- pubs:995523
- Source identifiers:
-
995523
- Deposit date:
- 2019-05-05
Terms of use
- Copyright holder:
- J Vekemans et al
- Copyright date:
- 2019
- Notes:
- © The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
- Licence:
- CC Attribution (CC BY)
Metrics
If you are the owner of this record, you can report an update to it here: Report update to this record